Literature DB >> 19267700

Hot and cold cognition in unmedicated depressed subjects with bipolar disorder.

Jonathan P Roiser1, Dara M Cannon, Shilpa K Gandhi, Joana Taylor Tavares, Kristine Erickson, Suzanne Wood, Jacqueline M Klaver, Luke Clark, Carlos A Zarate, Barbara J Sahakian, Wayne C Drevets.   

Abstract

OBJECTIVES: Neuropsychological studies in subjects with bipolar disorder (BD) have reported deficits on a variety of cognitive measures. However, because the majority of subjects were medicated at the time of testing in previous studies, it is currently unclear whether the pattern of deficits reported is related to BD itself or to psychotropic medication. We addressed this issue by examining cognitive performance in a group of unmedicated, currently depressed subjects with BD.
METHODS: Forty-nine unmedicated subjects who met DSM-IV criteria for BD, depressed phase, and 55 control subjects participated in this study. Most patients were diagnosed with bipolar II disorder. Performance on emotion-dependent, or 'hot', and emotion-independent, or 'cold', cognitive tasks was assessed using tests from the Cambridge Neuropsychological Test Automated Battery.
RESULTS: The groups were well matched with respect to general intelligence and demographic variables. Deficits in the unmedicated depressed BD group were apparent on tests tapping 'hot' cognitive processing, for example the Cambridge Gamble task and the Probabilistic Reversal Learning task. However, other than a deficit on the Spatial Span test in the depressed BD subjects, the groups performed equivalently on most measures of 'cold' cognitive processing, for example visual memory, attention, and working memory.
CONCLUSIONS: These data suggest that deficits on tests involving reward processing, short-term spatial memory storage, and sensitivity to negative feedback in depressed BD subjects represent an effect of the illness itself and not mood-stabilizing medication.

Entities:  

Mesh:

Year:  2009        PMID: 19267700      PMCID: PMC2670985          DOI: 10.1111/j.1399-5618.2009.00669.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  54 in total

1.  Sustained attention deficit in bipolar disorder is not a working memory impairment in disguise.

Authors:  Catherine J Harmer; Luke Clark; Louise Grayson; Guy M Goodwin
Journal:  Neuropsychologia       Date:  2002       Impact factor: 3.139

2.  Neural evidence for enhanced error detection in major depressive disorder.

Authors:  Pearl H Chiu; Patricia J Deldin
Journal:  Am J Psychiatry       Date:  2007-04       Impact factor: 18.112

3.  A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder.

Authors:  Lucy J Robinson; Jill M Thompson; Peter Gallagher; Utpal Goswami; Allan H Young; I Nicol Ferrier; P Brian Moore
Journal:  J Affect Disord       Date:  2006-03-06       Impact factor: 4.839

4.  Cognitive impairment in remission in bipolar affective disorder.

Authors:  J S Rubinsztein; A Michael; E S Paykel; B J Sahakian
Journal:  Psychol Med       Date:  2000-09       Impact factor: 7.723

5.  The Inventory for Depressive Symptomatology (IDS): preliminary findings.

Authors:  A J Rush; D E Giles; M A Schlesser; C L Fulton; J Weissenburger; C Burns
Journal:  Psychiatry Res       Date:  1986-05       Impact factor: 3.222

6.  A new depression scale designed to be sensitive to change.

Authors:  S A Montgomery; M Asberg
Journal:  Br J Psychiatry       Date:  1979-04       Impact factor: 9.319

Review 7.  A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic?

Authors:  Konstantinos N Fountoulakis; Eduard Vieta; Constantin Bouras; Grigorios Notaridis; Panteleimon Giannakopoulos; George Kaprinis; Hagop Akiskal
Journal:  Int J Neuropsychopharmacol       Date:  2007-05-17       Impact factor: 5.176

8.  Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed.

Authors:  B C Beats; B J Sahakian; R Levy
Journal:  Psychol Med       Date:  1996-05       Impact factor: 7.723

9.  A comparison of cognitive functioning in medicated and unmedicated subjects with bipolar depression.

Authors:  M Kathleen Holmes; Kristine Erickson; David A Luckenbaugh; Wayne C Drevets; Earle E Bain; Dara M Cannon; Joseph Snow; Barbara J Sahakian; Husseini K Manji; Carlos A Zarate
Journal:  Bipolar Disord       Date:  2008-11       Impact factor: 6.744

10.  Distinct profiles of neurocognitive function in unmedicated unipolar depression and bipolar II depression.

Authors:  Joana V Taylor Tavares; Luke Clark; Dara M Cannon; Kristine Erickson; Wayne C Drevets; Barbara J Sahakian
Journal:  Biol Psychiatry       Date:  2007-09-07       Impact factor: 13.382

View more
  29 in total

1.  Trait "pessimism" is associated with increased sensitivity to negative feedback in rats.

Authors:  Rafal Rygula; Piotr Popik
Journal:  Cogn Affect Behav Neurosci       Date:  2016-06       Impact factor: 3.282

2.  Common and distinct brain activity associated with risky and ambiguous decision-making.

Authors:  Ranjita Poudel; Michael C Riedel; Taylor Salo; Jessica S Flannery; Lauren D Hill-Bowen; Simon B Eickhoff; Angela R Laird; Matthew T Sutherland
Journal:  Drug Alcohol Depend       Date:  2020-02-04       Impact factor: 4.492

3.  Cognitive flexibility and performance in children and adolescents with threshold and sub-threshold bipolar disorder.

Authors:  Daniel P Dickstein; David Axelson; Alexandra B Weissman; Shirley Yen; Jeffrey I Hunt; Benjamin I Goldstein; Tina R Goldstein; Fangzi Liao; Mary Kay Gill; Heather Hower; Thomas W Frazier; Rasim S Diler; Eric A Youngstrom; Mary A Fristad; L Eugene Arnold; Robert L Findling; Sarah M Horwitz; Robert A Kowatch; Neal D Ryan; Michael Strober; Boris Birmaher; Martin B Keller
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-10-05       Impact factor: 4.785

4.  Brain circuitry associated with the development of substance use in bipolar disorder and preliminary evidence for sexual dimorphism in adolescents.

Authors:  Elizabeth T C Lippard; Carolyn M Mazure; Jennifer A Y Johnston; Linda Spencer; Judah Weathers; Brian Pittman; Fei Wang; Hilary P Blumberg
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

5.  An Overview of Psychological and Neurobiological Mechanisms by which Early Negative Experiences Increase Risk of Mood Disorders.

Authors:  Stefanie Hassel; Margaret C McKinnon; Andrée M Cusi; Glenda M Macqueen
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2011-11

6.  Temporal discounting of rewards in patients with bipolar disorder and schizophrenia.

Authors:  Woo-Young Ahn; Olga Rass; Daniel J Fridberg; Anthony J Bishara; Jennifer K Forsyth; Alan Breier; Jerome R Busemeyer; William P Hetrick; Amanda R Bolbecker; Brian F O'Donnell
Journal:  J Abnorm Psychol       Date:  2011-08-29

7.  Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder.

Authors:  D M Cannon; J K Klaver; S K Gandhi; G Solorio; S A Peck; K Erickson; N Akula; J Savitz; W C Eckelman; M L Furey; B J Sahakian; F J McMahon; W C Drevets
Journal:  Mol Psychiatry       Date:  2010-03-30       Impact factor: 15.992

8.  Neurocognition in bipolar disorder and juvenile bipolar disorder.

Authors:  Catherine M Cahill; Garry Walter; Gin S Malhi
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2009-08

9.  Increased reward-oriented impulsivity in older bipolar patients: A preliminary study.

Authors:  Isabelle E Bauer; Breno Satler Diniz; Thomas D Meyer; Antonio Lucio Teixeira; Marsal Sanches; Danielle Spiker; Giovana Zunta-Soares; Jair C Soares
Journal:  J Affect Disord       Date:  2017-08-31       Impact factor: 4.839

10.  Reversal-learning deficits in childhood-onset bipolar disorder across the transition from childhood to young adulthood.

Authors:  Ezra Wegbreit; Grace K Cushman; Alexandra B Weissman; Erin Bojanek; Kerri L Kim; Ellen Leibenluft; Daniel P Dickstein
Journal:  J Affect Disord       Date:  2016-05-26       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.